All drugs

Indications for Use

Azacitidine (for subcutaneous or intravenous administration) is indicated for the treatment of adult patients with the following subtypes of French-American-British (FAB) myelodysplastic syndrome (MDS): refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (in the presence of neutropenia or thrombocytopenia, as well as in the presence of transfusion requirements), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMML). Azacitidine is also indicated for the treatment of children 1 month of age and older with newly diagnosed juvenile myelomonocytic leukemia (JMML).

Dosage 15 mg price 220$

 Colorectal cancer

 Lansurf is indicated as monotherapy for adult patients with metastatic colorectal cancer who have previously undergone or are ineligible for existing therapies, including fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, as well as anti-VEGF and anti-EGFR agents.

 Gastric cancer

 Lansurf is indicated as monotherapy for adult patients with metastatic gastric cancer, including patients with gastroesophageal junction adenocarcinoma, who have previously received at least two systemic therapies at disease progression.

All Europe delivery. Shipping time 7-10 days. Price for shipping individual for each country. Usually 40-50 euro. Payment when sending the goods. 

Worldwide shipping possible too. 

Method of administration and dosage

Zavicefta is recommended for use in the treatment of infections caused by aerobic gram-negative microorganisms in adults and children aged 3 months and older who have limited treatment options, only after consultation with a physician with relevant experience in the treatment of infectious diseases.

Jyseleca filgotinib) is a Janus kinase 1 (JAK1) inhibitor indicated for the treatment of adults with moderate to severe active rheumatoid arthritis (RA).

Indications for the active ingredients of the drug Xospata

Relapsed or refractory acute myeloid leukemia (AML) with FLT3 mutations - as monotherapy.

Take at a dose of 120 mg 1 time per day.